Kupperman BD, Keyloun KR, Campbell JH, Zhou X, Davenport E, Bakri SJ. Decreased vision improvement in DME eyes with longer duration or larger amounts of excess edema: a post-hoc analysis of protocol T. Presented at the 2021 54th Retina Society Annual Scientific Meeting; September 29, 2021. Chicago, IL.
Augustin M, Korman N, Zhao Y, Gilloteau I, Herrera V, Sherif B, Williams N, Blauvelt A. Secukinumab skin clearance is associated with greater improvements in skin-related quality of life. Presented at the 2016 AAD Summer Meeting; July 2016. Boston, MA.
Dickinson KL, Pattanayak SK, Yang J, Patil SR, Praharaj P, Mallick RK, Blitstein JL, Poulos C. Nature's call: can social mobilization promote toilet use and reduce child diarrhea? Results from a community randomized trial in Orissa, India. Presented at the Infectious Diseases Conference at Cornell University; September 2007.
Trump DL, Wilding G, Miller K, Small E, Soulie P, Trachtenberg J, Raabe N, Heyes AE, Das-Gupta A. Pilot trials of ZD1839 ('Iressa'), an orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor, in combination with mitoxantrone/prednisolone or docetaxel/estramustine in patients with hormone-refractory prostate cancer. Presented at the American Urology Association; April 2003. Chicago, IL.
Neighbors DM, Candrilli SD. Concomitant medication costing using clinical trial data: a case study. Presented at the 2000 ISPOR 5th Annual International Meeting; May 2000. Arlington, VA.